Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03640494 · ClinicalTrials.gov registry record
Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 57
- Enrollment target
NCT03640494 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 57 participants.
The verdict
NCT03640494 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a novel noninvasive bedside optical coherence tomography (OCT) imaging technique in newborn infants with HIE that improves our ability to assess the range of retinal effects from HIE and to diagnose and monitor treatments of HIE.
Interventions
- DEVICE Optical Coherence Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2018-08-28 |
| Est. Completion | 2021-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03640494
The ClinicalTrials.gov registry entry for NCT03640494 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optical Coherence Tomography is the first listed.
NCT03640494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03640494 about?
NCT03640494 is a clinical study titled "Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants". The purpose of this study is to develop a novel noninvasive bedside optical coherence tomography (OCT) imaging technique in newborn infants with HIE that improves our ability to assess the range of retinal effects from HIE and to diagnose and monitor treatments of HIE.
What is the current status of trial NCT03640494?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2018-08-28. Estimated completion is 2021-02-28.
What interventions are being tested in trial NCT03640494?
The interventions under investigation include: Optical Coherence Tomography (DEVICE).
Who is sponsoring clinical trial NCT03640494?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.